Consulting firm Deloitte has been contracted to undertake a three-month review of NSW Health's Electronic Recording and Reporting of Controlled Drugs (ERRCD) capabilities as part of the move towards a national real-time prescription monitoring (RTPM) system.

The $350,000 contract will see Deloitte report back to eHealth NSW in October with an evaluation of the required business change, ICT delivery approach, and support and governance requirements of the national RTPM and NSW ERRCD capabilities.

An eHealth NSW spokesperson said the analysis will assist NSW Health with future decision making on RTPM.